Houjie Liang

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen et al. · The Lancet Oncology · 2008 · 5.8K citations

Medicine, Oncology, Pharmacotherapy +11

First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study

Yi‐Long Wu, Caicun Zhou, Chong Kin Liam et al. · Annals of Oncology · 2015 · 735 citations

Medicine, Oncology, Pharmacology +13

Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infection

Ran He, Shiyue Hou, Cheng Liu et al. · Nature · 2016 · 687 citations

Life Sciences, Cell Biology, Immunology +14

Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers

Chengcheng Zhang, Zhe Wang, Zhi Yang et al. · Molecular Therapy · 2017 · 444 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression

Wei Xiang, Rongchen Shi, Xia Kang et al. · Nature Communications · 2018 · 242 citations · Full text

Life Sciences, Immunology, Oncology +17